Depression and coronary heart disease: mechanisms, interventions, and treatments

Area of Science:

• Cardiovascular Science
• Psychiatry
• Medical Research

Background:

• Coronary heart disease (CHD) presents a significant global health and economic challenge.
• Depression is increasingly recognized as an independent risk factor for CHD, impacting its onset, progression, and prognosis.
• Despite growing attention, the precise mechanisms by which depression contributes to CHD remain incompletely understood.

Purpose of the Study:

• To review the current understanding of depression as a risk factor for CHD.
• To explore the proposed biological mechanisms linking depression to CHD.
• To discuss the controversies surrounding antidepressant treatment in CHD patients with depression.

Main Methods:

• Literature review of existing research on depression and CHD.
• Analysis of proposed pathophysiological pathways including inflammation, HPA axis, ANS dysfunction, platelet and endothelial function, lipid metabolism, and genetics.
• Examination of studies on antidepressant treatment efficacy and safety in CHD patients.

Main Results:

• Depression influences multiple biological systems implicated in CHD development, including inflammatory response, Hypothalamic-pituitary-adrenocortical (HPA) axis and Autonomic Nervous System (ANS) dysfunction, platelet and endothelial function, lipid metabolism, and genetic factors.
• The role of these mechanisms in the interplay between depression and CHD requires further elucidation.
• The use and impact of antidepressant treatments in patients with comorbid depression and CHD are subjects of ongoing debate.

Conclusions:

• Depression is a significant, independent risk factor for coronary heart disease.
• Further research is essential to clarify the complex mechanisms underlying the depression-CHD link.
• Investigating the optimal management of depression in CHD patients is critical for improving cardiovascular outcomes.